May Hill Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
5,713
+321
+6% +$84.7K 0.3% 63
2026
Q2
$1.37M Buy
5,392
+247
+5% +$57.6K 0.29% 63
2026
Q1
$1.26M Buy
5,145
+1,591
+45% +$371K 0.32% 66
2025
Q4
$736K Buy
3,554
+218
+7% +$43.1K 0.2% 81
2025
Q3
$619K Buy
3,336
+814
+32% +$139K 0.18% 83
2025
Q2
$385K Buy
2,522
+86
+4% +$13.2K 0.13% 114
2025
Q1
$404K Buy
2,436
+261
+12% +$40.8K 0.15% 100
2024
Q4
$315K Buy
+2,175
New +$337K 0.12% 113

Other funds holding JNJ

May Hill Capital's JNJ Position: Q3 2026 in Review

May Hill Capital increased its Johnson & Johnson (JNJ) stake by 6% in Q3 2026, buying an estimated $84.7K and bringing the position to 5,713 shares worth $1.51M. The position accounts for 0.3% of the portfolio, ranked #63.

May Hill Capital first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,709 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • May Hill Capital held 5,713 shares of Johnson & Johnson worth $1.51M as of Q3 2026.
  • May Hill Capital bought 321 Johnson & Johnson shares in Q3 2026, an estimated $84.7K.
  • Johnson & Johnson made up 0.3% of May Hill Capital's portfolio in Q3 2026, its #63 holding.
  • May Hill Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,709 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.